These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 2955246)

  • 1. Intracellular studies on the dopamine-induced firing inhibition of neostriatal neurons in vitro: evidence for D1 receptor involvement.
    Calabresi P; Mercuri N; Stanzione P; Stefani A; Bernardi G
    Neuroscience; 1987 Mar; 20(3):757-71. PubMed ID: 2955246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutual inhibitory effects between dopamine and carbachol on the excitatory synaptic transmission in the rat neostriatum.
    Hsu KS; Huang CC; Gean PW
    J Neurosci Res; 1996 Oct; 46(1):34-41. PubMed ID: 8892103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mechanism underlying dopamine D1 and D2 receptor-mediated inhibition of dopaminergic neurones in the ventral tegmental area in vitro.
    Momiyama T; Todo N; Sasa M
    Br J Pharmacol; 1993 Aug; 109(4):933-40. PubMed ID: 8104652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory action of dopamine involves a subthreshold Cs(+)-sensitive conductance in neostriatal neurons.
    Pacheco-Cano MT; Bargas J; Hernández-López S; Tapia D; Galarraga E
    Exp Brain Res; 1996 Jul; 110(2):205-11. PubMed ID: 8836685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholecystokinin octapeptide potentiates the inhibitory response mediated by D2 dopamine receptors in slices of the ventral tegmental area of the brain in the rat.
    Stittsworth JD; Mueller AL
    Neuropharmacology; 1990 Feb; 29(2):119-27. PubMed ID: 2184375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours.
    Fletcher GH; Starr MS
    Neuroscience; 1987 Dec; 23(3):1001-10. PubMed ID: 2963970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of effects of D-1 and D-2 dopamine receptor agonists on neurons in the rat caudate putamen: an electrophysiological study.
    Hu XT; Wang RY
    J Neurosci; 1988 Nov; 8(11):4340-8. PubMed ID: 2972814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excitatory and inhibitory action of dopamine on hippocampal neurons in vitro. Involvement of D2 and D1 receptors.
    Smiałowski A; Bijak M
    Neuroscience; 1987 Oct; 23(1):95-101. PubMed ID: 2960914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of dopaminergic terminal excitability by D1 selective agents: further characterization.
    Diana M; Young SJ; Groves PM
    Neuroscience; 1991; 42(2):441-9. PubMed ID: 1680226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct and indirect actions of dopamine on the membrane potential in medium spiny neurons of the mouse neostriatum.
    Yasumoto S; Tanaka E; Hattori G; Maeda H; Higashi H
    J Neurophysiol; 2002 Mar; 87(3):1234-43. PubMed ID: 11877497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functionally distinct subpopulations of striatal neurons are differentially regulated by GABAergic and dopaminergic inputs--II. In vitro analysis.
    Nisenbaum ES; Grace AA; Berger TW
    Neuroscience; 1992; 48(3):579-93. PubMed ID: 1351271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D2-dopamine receptor-mediated inhibition of intracellular Ca2+ mobilization and release of acetylcholine from guinea-pig neostriatal slices.
    Fujiwara H; Kato N; Shuntoh H; Tanaka C
    Br J Pharmacol; 1987 Jun; 91(2):287-97. PubMed ID: 2886167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous and exogenous dopamine depress EPSCs in rat nucleus accumbens in vitro via D1 receptors activation.
    Harvey J; Lacey MG
    J Physiol; 1996 Apr; 492 ( Pt 1)(Pt 1):143-54. PubMed ID: 8730590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous dopamine and dopaminergic agonists modulate synaptic excitation in neostriatum: intracellular studies from naive and catecholamine-depleted rats.
    Calabresi P; Benedetti M; Mercuri NB; Bernardi G
    Neuroscience; 1988 Oct; 27(1):145-57. PubMed ID: 2904663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
    Van Vliet BJ; Mulder AH; Schoffelmeer AN
    J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D1/D5 receptor activation modulates a persistent sodium current in rat prefrontal cortical neurons in vitro.
    Gorelova NA; Yang CR
    J Neurophysiol; 2000 Jul; 84(1):75-87. PubMed ID: 10899185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of dopaminergic terminal excitability by D1 selective agents.
    Diana M; Young SJ; Groves PM
    Neuropharmacology; 1989 Jan; 28(1):99-101. PubMed ID: 2522599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional evidence for selective dopamine D-1 receptor blockade by SCH 23390.
    Hyttel J
    Neuropharmacology; 1984 Dec; 23(12A):1395-401. PubMed ID: 6152023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors.
    Dahmer MK; Senogles SE
    J Neurochem; 1996 Jan; 66(1):222-32. PubMed ID: 8522958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.